Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Clin Invest
2009 Mar 01;1193:565-72. doi: 10.1172/JCI37865.
Show Gene links
Show Anatomy links
Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.
Bending D
,
De la Peña H
,
Veldhoen M
,
Phillips JM
,
Uyttenhove C
,
Stockinger B
,
Cooke A
.
???displayArticle.abstract???
Th17 cells are involved in the pathogenesis of many autoimmune diseases, but it is not clear whether they play a pathogenic role in type 1 diabetes. Here we investigated whether mouse Th17 cells with specificity for an islet antigen can induce diabetes upon transfer into NOD/SCID recipient mice. Induction of diabetes in NOD/SCID mice via adoptive transfer of Th1 cells from BDC2.5 transgenic mice was prevented by treatment of the recipient mice with a neutralizing IFN-γ-specific antibody. This result suggested a major role of Th1 cells in the induction of disease in this model of type 1 diabetes. Nevertheless, transfer of highly purified Th17 cells from BDC2.5 transgenic mice caused diabetes in NOD/SCID recipients with similar rates of onset as in transfer of Th1 cells. However, treatment with neutralizing IL-17-specific antibodies did not prevent disease. Instead, the transferred Th17 cells, completely devoid of IFN-γ at the time of transfer, rapidly converted to secrete IFN-γ in the NOD/SCID recipients. Purified Th17 cells also upregulated Tbet and secreted IFN-γ upon exposure to IL-12 in vitro and in vivo in NOD/SCID recipients. These results indicate substantial plasticity of Th17 commitment toward a Th1-like profile.
Annunziato,
Phenotypic and functional features of human Th17 cells.
2007, Pubmed
Annunziato,
Phenotypic and functional features of human Th17 cells.
2007,
Pubmed
Bettelli,
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
2006,
Pubmed
Boyton,
Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread.
2005,
Pubmed
Grewal,
Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism.
2002,
Pubmed
Harrington,
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
2005,
Pubmed
Healey,
In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice.
1995,
Pubmed
Hultgren,
Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice.
1996,
Pubmed
Hutchings,
Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages.
1990,
Pubmed
Ivanov,
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
2006,
Pubmed
Jain,
Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production.
2008,
Pubmed
Kanagawa,
Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci.
2000,
Pubmed
Katz,
T helper cell subsets in insulin-dependent diabetes.
1995,
Pubmed
Katz,
Following a diabetogenic T cell from genesis through pathogenesis.
1993,
Pubmed
Lexberg,
Th memory for interleukin-17 expression is stable in vivo.
2008,
Pubmed
Li,
Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.
2006,
Pubmed
Luger,
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
2008,
Pubmed
Löhning,
Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors.
2008,
Pubmed
Mangan,
Transforming growth factor-beta induces development of the T(H)17 lineage.
2006,
Pubmed
Mathur,
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype.
2006,
Pubmed
Moritani,
Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
1998,
Pubmed
Mueller,
Mechanism underlying counterregulation of autoimmune diabetes by IL-4.
1997,
Pubmed
Murphy,
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.
1996,
Pubmed
Nicoletti,
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse.
1996,
Pubmed
Oppmann,
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
2000,
Pubmed
Park,
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.
2005,
Pubmed
Phillips,
Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes.
2001,
Pubmed
Raine,
Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes.
2006,
Pubmed
Röhn,
Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
2006,
Pubmed
Serreze,
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice.
2000,
Pubmed
Simpson,
Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice.
2003,
Pubmed
Sonderegger,
Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis.
2006,
Pubmed
Streeck,
Rapid ex vivo isolation and long-term culture of human Th17 cells.
2008,
Pubmed
Trembleau,
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.
1995,
Pubmed
Uyttenhove,
Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis.
2006,
Pubmed
Veldhoen,
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.
2006,
Pubmed
Veldhoen,
Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.
2008,
Pubmed
Veldhoen,
Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.
2006,
Pubmed
Wang,
Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes.
1997,
Pubmed
Yang,
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.
2008,
Pubmed
Yang,
Autoimmune diabetes is blocked in Stat4-deficient mice.
2004,
Pubmed
Ymer,
Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains.
2002,
Pubmed
You,
Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
2007,
Pubmed
Zhou,
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.
2008,
Pubmed
